- Systems
- Consumables
- Point-of-Care Testing Devices
North America Hemostasis Diagnostics Market size was valued at USD 3.2 billion in 2022 and is poised to grow at a CAGR of 9.5% from 2023-2029. Hemostasis diagnostics are the devices used to determine the hemostatic defects, which cause excessive bleeding. Hemostasis is defined as the stopping or slowing the blood flow from damaged blood vessel. During the hemostasis, blood changes from liquid state to the gelatinous state. Hemostasis maintained in the body by three mechanisms namely, blood coagulation, platelet plug formation, and vasoconstriction. Hemostasis diagnostics may help to predict the cause of bleeding during surgery by identifying the hemostatic defects in patients. Different types of tests such as prothrombin test, activated clotting time, platelet function, and other coagulation tests are carried to identify the hemostasis defects. However, high cost of advanced hemostasis products, and stringent regulations for the test approvals are expected to hamper the growth of hemostasis diagnostics market.
North America Hemostasis Diagnostics Market Dynamics
Increase in the prevalence of hemophilia disease in U.S. and Canada (according to Canadian Hemophilia Society, approximately 35,000 Canadians are having an inherited bleeding disorder gene), rise in number of surgeries, technological advancements in the hemostasis diagnostics such as accurate results in less time, and rise in R&D investment for novel tests and devices innovation are expected to boost the hemostasis diagnostics market
North America Hemostasis Diagnostics Market Country Analysis
Geographically, North America hemostasis diagnostics market has been segmented into U.S. and Canada. U.S. hemostasis diagnostics market is projected to grow at a significant CAGR owing to increase in the prevalence of hemophilia disease. For instance, according to Centre for Disease Control and Prevention 2015, approximately 20,000 people are suffering from hemophilia in U.S., increase in the R&D activities for the development of newer tests, and FDA clearance for the newer diagnostics tests are anticipated to fuel the market. Canada hemostasis diagnostics market expected to grow at notable rate due to increase in the prevalence of hemophilia disease, rise in prevalence & incidence of various cardiovascular diseases and expansion of business by the market players in Canada are expected to propel the market. For instance, in February 2012, Roche collaborated with Technoclone to expand the reagent portfolio for coagulation diagnostics in US and Canada.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
North America Hemostasis Diagnostics Market Segmentation
By Product Type
By Test Type
- Fibrinogen Test
- Activated Clotting Time
- Platelet Function
- Prothrombin Time
- Heparin & Protamine Dose-Response Test For ACT
- Activated Partial Thromboplastin Time
- Anti-Factor Xa
- Other Coagulation Tests
By Technology
- Optical
- Mechanical
- Electrochemical
- Others
By End User
- Hospitals
- Clinics
- Diagnostic Centres
- Others (POC)
Frequently Asked Questions
The north america hemostasis diagnostics market is projected to expand at a CAGR of 9.5% during the forecast period
Hoffmann-La Roche Ltd, Sysmex Corporation, Abbott Laboratories, Alere Inc, Nihon Kohden Corporation
Canada is the fastest-growing region for north america hemostasis diagnostics market
| 1.Executive Summary |
| 2. North America Hemostasis Diagnostics Market Introduction |
| 2.1. North America Hemostasis Diagnostics Market - Taxonomy |
| 2.2. North America Hemostasis Diagnostics Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Test Type |
| 2.2.3.Technology |
| 2.2.4.End User |
| 2.2.5.Country |
| 3. North America Hemostasis Diagnostics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. North America Hemostasis Diagnostics Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. North America Hemostasis Diagnostics Market By Product Type , 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Systems |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Consumables |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Point-of-Care Testing Devices |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. North America Hemostasis Diagnostics Market By Test Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Fibrinogen Test |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Activated Clotting Time |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Platelet Function |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Prothrombin Time |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Heparin & Protamine Dose-Response Test For ACT |
| 6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Activated Partial Thromboplastin Time |
| 6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 6.7. Anti-Factor Xa |
| 6.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.7.3. Market Opportunity Analysis |
| 6.8. Other Coagulation Tests |
| 6.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.8.3. Market Opportunity Analysis |
| 7. North America Hemostasis Diagnostics Market By Technology, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. Optical |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Mechanical |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Electrochemical |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. North America Hemostasis Diagnostics Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. Hospitals |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Clinics |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Diagnostic Centres |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Others (POC) |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 9. North America Hemostasis Diagnostics Market By Country, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. United States of America (USA) |
| 9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Canada |
| 9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Mexico |
| 9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 10.United States of America (USA) Hemostasis Diagnostics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Systems |
| 10.1.2.Consumables |
| 10.1.3.Point-of-Care Testing Devices |
| 10.2. Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Fibrinogen Test |
| 10.2.2.Activated Clotting Time |
| 10.2.3.Platelet Function |
| 10.2.4.Prothrombin Time |
| 10.2.5.Heparin & Protamine Dose-Response Test For ACT |
| 10.2.6.Activated Partial Thromboplastin Time |
| 10.2.7.Anti-Factor Xa |
| 10.2.8.Other Coagulation Tests |
| 10.3. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Optical |
| 10.3.2.Mechanical |
| 10.3.3.Electrochemical |
| 10.3.4.Others |
| 10.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Hospitals |
| 10.4.2.Clinics |
| 10.4.3.Diagnostic Centres |
| 10.4.4.Others (POC) |
| 11.Canada Hemostasis Diagnostics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Systems |
| 11.1.2.Consumables |
| 11.1.3.Point-of-Care Testing Devices |
| 11.2. Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Fibrinogen Test |
| 11.2.2.Activated Clotting Time |
| 11.2.3.Platelet Function |
| 11.2.4.Prothrombin Time |
| 11.2.5.Heparin & Protamine Dose-Response Test For ACT |
| 11.2.6.Activated Partial Thromboplastin Time |
| 11.2.7.Anti-Factor Xa |
| 11.2.8.Other Coagulation Tests |
| 11.3. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Optical |
| 11.3.2.Mechanical |
| 11.3.3.Electrochemical |
| 11.3.4.Others |
| 11.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Hospitals |
| 11.4.2.Clinics |
| 11.4.3.Diagnostic Centres |
| 11.4.4.Others (POC) |
| 12.Mexico Hemostasis Diagnostics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Systems |
| 12.1.2.Consumables |
| 12.1.3.Point-of-Care Testing Devices |
| 12.2. Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Fibrinogen Test |
| 12.2.2.Activated Clotting Time |
| 12.2.3.Platelet Function |
| 12.2.4.Prothrombin Time |
| 12.2.5.Heparin & Protamine Dose-Response Test For ACT |
| 12.2.6.Activated Partial Thromboplastin Time |
| 12.2.7.Anti-Factor Xa |
| 12.2.8.Other Coagulation Tests |
| 12.3. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Optical |
| 12.3.2.Mechanical |
| 12.3.3.Electrochemical |
| 12.3.4.Others |
| 12.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Hospitals |
| 12.4.2.Clinics |
| 12.4.3.Diagnostic Centres |
| 12.4.4.Others (POC) |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Hoffmann-La Roche Ltd. |
| 13.2.2.Sysmex Corporation |
| 13.2.3.Abbott Laboratories |
| 13.2.4.Alere Inc. |
| 13.2.5.Nihon Kohden Corporation |
| 13.2.6.Siemens Healthineers |
| 13.2.7.Danaher Corporation |
| 13.2.8.Instrumentation Laboratory |
| 13.2.9.Grifols S.A |
| 13.2.10.Beckman Coulter |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
- Hoffmann-La Roche Ltd.
- Sysmex Corporation
- Abbott Laboratories
- Alere Inc.
- Nihon Kohden Corporation
- Siemens Healthineers
- Danaher Corporation
- Instrumentation Laboratory
- Grifols S.A
- Beckman Coulter